To report an Adverse Event or Product Quality Complaint, please click here
Additional medical information about any of Cardiome’s products could be requested at email@example.com.
Correvio Receives Complete Response Letter from U.S. FDA for BRINAVESS and Provides Update on Recent Events
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
Correvio Announces Outcome of FDA Advisory Committee Meeting Reviewing BRINAVESS™ for the Treatment of Recent Onset Atrial Fibrillation
Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss BRINAVESS™ for Recent Onset Atrial Fibrillation
Correvio to Present at the Piper Jaffray 31st Annual Healthcare Conference
Correvio Announces Presentation of New BRINAVESS™ Spectrum Data at the American Heart Association 2019 Annual Meeting
Correvio Reports Third Quarter 2019 Financial Results
Correvio to Report Third Quarter 2019 Financial Results
Correvio Announces FDA Advisory Committee Meeting to Review BRINAVESS for Recent Onset Atrial Fibrillation
Correvio to Present at the 2019 Cantor Global Healthcare Conference
Copyright 2018 Correvio Pharma Corp. All rights reserved.
By following this link you will be leaving the correvio.com website. Please note that Correvio does not take responsibility for the content displayed on other websites: